532
Views
29
CrossRef citations to date
0
Altmetric
Review

Staphylococcus lugdunensis: the coagulase-negative staphylococcus you don’t want to ignore

&
Pages 901-907 | Published online: 10 Jan 2014

References

  • Pfaller MA, Jones RN, Doern GV, Sader HS, Kugler KC, Beach ML. Survey of blood stream infections attributable to Gram-positive cocci: frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America from the SENTRY Antimicrobial Surveillance Program. SENTRY Participants Group. Diagn. Microbiol. Infect. Dis.33(4), 283–297 (1999).
  • Jarlov JO, Hojbjerg T, Busch-Sorensen C et al. Coagulase-negative staphylococci in Danish blood cultures: species distribution and antibiotic susceptibility. J. Hosp. Infect.32(3), 217–227 (1996).
  • Shin JH, Jung HJ, Lee HR, Kim JH, Kim HR, Lee JN. Prevalence, identification, and antimicrobial susceptibility of Staphylococcus lugdunensis from various clinical specimens in Korea. Jpn J. Infect. Dis.60(5), 312–313 (2007).
  • Choi SH, Chung JW, Lee EJ et al. Incidence, characteristics, and outcomes of Staphylococcus lugdunensis bacteremia. J. Clin. Microbiol.48(9), 3346–3349 (2010).
  • Kawamura Y, Hou XG, Sultana F et al. Distribution of Staphylococcus species among human clinical specimens and emended description of Staphylococcus caprae. J. Clin. Microbiol.36(7), 2038–2042 (1998).
  • De Paulis AN, Predari SC, Chazarreta CD, Santoianni JE. Five-test simple scheme for species-level identification of clinically significant coagulase-negative staphylococci. J. Clin. Microbiol.41(3), 1219–1224 (2003).
  • Kleeman KT, Bannerman TL, Kloos WE. Species distribution of coagulase-negative staphylococcal isolates at a community hospital and implications for selection of staphylococcal identification procedures. J. Clin. Microbiol.31(5), 1318–1321 (1993).
  • Kleiner E, Monk AB, Archer GL, Forbes BA. Clinical significance of Staphylococcus lugdunensis isolated from routine cultures. Clin. Infect. Dis.51(7), 801–803 (2010).
  • Herchline TE, Ayers LW. Occurrence of Staphylococcus lugdunensis in consecutive clinical cultures and relationship of isolation to infection. J. Clin. Microbiol.29(3), 419–421 (1991).
  • Bieber L, Kahlmeter G. Staphylococcus lugdunensis in several niches of the normal skin flora. Clin. Microbiol. Infect.16(4), 385–388 (2010).
  • Freney J. Staphylococcus lugdunensis sp. nov. and Staphylococcus schleiferi sp. nov., two species from human clinical specimens. Int. J. Syst. Bacteriol.38(2), 168–172 (1988).
  • Pirila L, Soderstrom KO, Hietarinta M, Jalava J, Kyto V, Toivanen A. Fatal myocardial necrosis caused by Staphylococcus lugdunensis and cytomegalovirus in a patient with scleroderma. J. Clin. Microbiol.44(6), 2295–2297 (2006).
  • Bhanot N, Sahud AG, Bhat S, Lane S, Manyam H, Chan-Tompkins NH. Fever of unknown origin: a case of cardiac myxoma infected with Staphylococcus lugdunensis. South. Med. J.103(7), 697–700 (2010).
  • Patil R, Patil T, Hussain KM. Staphylococcus lugdunensis native tricuspid valve endocarditis: a case report and review of literature. J. Gen. Intern. Med. DOI: 10.1007/s11606-011-1718-5 (2011) (Epub ahead of print).
  • Longauerova A. Coagulase negative staphylococci and their participation in pathogenesis of human infections. Bratisl. Lek. Listy107(11–12), 448–452 (2006).
  • Liu PY, Huang YF, Tang CW et al.Staphylococcus lugdunensis infective endocarditis: a literature review and analysis of risk factors. J. Microbiol. Immunol. Infect.43(6), 478–484 (2010).
  • Van Hoovels L, De Munter P, Colaert J et al. Three cases of destructive native valve endocarditis caused by Staphylococcus lugdunensis. Eur. J. Clin. Microbiol. Infect. Dis.24(2), 149–152 (2005).
  • De Hondt G, Ieven M, Vandermersch C, Colaert J. Destructive endocarditis caused by Staphylococcus lugdunensis. Case report and review of the literature. Acta. Clin. Belg.52(1), 27–30 (1997).
  • Koh TW, Brecker SJ, Layton CA. Successful treatment of Staphylococcus lugdunensis endocarditis complicated by multiple emboli: a case report and review of the literature. Int. J. Cardiol.55(2), 193–197 (1996).
  • Anguera I, Del Rio A, Miro JM et al.Staphylococcus lugdunensis infective endocarditis: description of 10 cases and analysis of native valve, prosthetic valve, and pacemaker lead endocarditis clinical profiles. Heart91(2), e10 (2005).
  • Baddour LM, Bettmann MA, Bolger AF et al. Nonvalvular cardiovascular device-related infections. Clin. Infect. Dis.38(8), 1128–1130 (2004).
  • Kamaraju S, Nelson K, Williams DN, Ayenew W, Modi KS. Staphylococcus lugdunensis pulmonary valve endocarditis in a patient on chronic hemodialysis. Am. J. Nephrol.19(5), 605–608 (1999).
  • Matthews PC, Missouris CG, Jordaan J, Lessing MP. Staphylococcus lugdunensis endocarditis following cardiac catheterisation. Int. J. Cardiol.130(1), 87–88 (2008).
  • Polenakovik H, Herchline T, Bacheller C, Bernstein J. Staphylococcus lugdunensis endocarditis after angiography. Mayo Clin. Proc.75(6), 656–657 (2000).
  • Fervenza FC, Contreras GE, Garratt KN, Steckelberg JM. Staphylococcus lugdunensis endocarditis: a complication of vasectomy? Mayo Clin. Proc.74(12), 1227–1230 (1999).
  • Patel R, Piper KE, Rouse MS, Uhl JR, Cockerill FR 3rd, Steckelberg JM. Frequency of isolation of Staphylococcus lugdunensis among staphylococcal isolates causing endocarditis: a 20-year experience. J. Clin. Microbiol.38(11), 4262–4263 (2000).
  • Kragsbjerg P, Bomfim-Loogna J, Tornqvist E, Soderquist B. Development of antimicrobial resistance in Staphylococcus lugdunensis during treatment-report of a case of bacterial arthritis, vertebral osteomyelitis and infective endocarditis. Clin. Microbiol. Infect.6(9), 496–499 (2000).
  • Karchmer AW, Longworth DL. Infections of intracardiac devices. Cardiol. Clin.21(2), 253–271, vii (2003).
  • Greig JM, Wood MJ. Staphylococcus lugdunensis vertebral osteomyelitis. Clin. Microbiol. Infect.9(11), 1139–1141 (2003).
  • Cooke RP, James SE, Sallomi DF. Infective discitis due to Staphylococcus lugdunensis – a case of missed opportunity. Br. J. Biomed. Sci.60(3), 162–164 (2003).
  • Guttmann G, Garazi S, Van Linthoudt D. Spondylodiscitis due to Staphylococcus lugdunensis. Clin. Exp. Rheumatol.18(2), 271–272 (2000).
  • Murdoch DR, Everts RJ, Chambers ST, Cowan IA. Vertebral osteomyelitis due to Staphylococcus lugdunensis. J. Clin. Microbiol.34(4), 993–994 (1996).
  • Thomas S, Hoy C, Capper R. Osteomyelitis of the ear canal caused by Staphylococcus lugdunensis. J. Infect.53(5), e227–e229 (2006).
  • Mei-Dan O, Mann G, Steinbacher G, Ballester SJ, Cugat RB, Alvarez PD. Septic arthritis with Staphylococcus lugdunensis following arthroscopic ACL revision with BPTB allograft. Knee Surg. Sports Traumatol. Arthrosc.16(1), 15–18 (2008).
  • Sampathkumar P, Osmon DR, Cockerill FR 3rd. Prosthetic joint infection due to Staphylococcus lugdunensis. Mayo. Clin. Proc.75(5), 511–512 (2000).
  • Weightman NC, Allerton KE, France J. Bone and prosthetic joint infection with Staphylococcus lugdunensis. J. Infect.40(1), 98–99 (2000).
  • Zinkernagel AS, Zinkernagel MS, Elzi MV et al. Significance of Staphylococcus lugdunensis bacteremia: report of 28 cases and review of the literature. Infection36(4), 314–321 (2008).
  • Woznowski M, Quack I, Bolke E et al. Fulminant Staphylococcus lugdunensis septicaemia following a pelvic varicella-zoster virus infection in an immune-deficient patient: a case report. Eur. J. Med. Res.15(9), 410–414 (2010).
  • Castro JG, Dowdy L. Septic shock caused by Staphylococcus lugdunensis. Clin. Infect. Dis.28(3), 681–682 (1999).
  • Pareja J, Gupta K, Koziel H. The toxic shock syndrome and Staphylococcus lugdunensis bacteremia. Ann. Intern. Med.128(7), 603–604 (1998).
  • Fadel HJ, Patel R, Vetter EA, Baddour LM. Clinical significance of a single Staphylococcus lugdunensis-positive blood culture. J. Clin. Microbiol.49(4), 1697–1699 (2011).
  • Tan TY, Ng SY, Ng WX. Clinical significance of coagulase-negative staphylococci recovered from nonsterile sites. J. Clin. Microbiol.44(9), 3413–3414 (2006).
  • Arias M, Tena D, Apellaniz M et al. Skin and soft tissue infections caused by Staphylococcus lugdunensis: report of 20 cases. Scand. J. Infect. Dis42(11–12), 879–884 (2010).
  • Bellamy R, Barkham T. Staphylococcus lugdunensis infection sites: predominance of abscesses in the pelvic girdle region. Clin. Infect. Dis.35(3), E32–E34 (2002).
  • Bocher S, Tonning B, Skov RL, Prag J. Staphylococcus lugdunensis, a common cause of skin and soft tissue infections in the community. J. Clin. Microbiol.47(4), 946–950 (2009).
  • Asnis DS, St John S, Tickoo R, Arora A. Staphylococcus lugdunensis breast abscess: is it real? Clin. Infect. Dis.36(10), 1348 (2003).
  • Lina B, Vandenesch F, Reverdy ME, Greenland T, Fleurette J, Etienne J. Non-puerperal breast infections due to Staphylococcus lugdunensis. Eur. J. Clin. Microbiol. Infect. Dis.13(8), 686–687 (1994).
  • Matthews PC, Lazarus R, Protheroe A, Milford C, Bowler IC. Acute necrotizing sinusitis caused by Staphylococcus lugdunensis. J. Clin. Microbiol.49(7), 2740–2742 (2011).
  • Shaaban HS, Choo HF, Sensakovic JW. A case of Staphylococcus lugdunensis related pyomyoma occurring after cesarean section. J. Glob. Infect. Dis.3(1), 101–102 (2011).
  • Bello C, Eskandar M, El GR, Sobande A, Nour H, Shafiq H. Staphylococcus lugdunensis endometritis: a case report. West Afr. J. Med.26(3), 243–245 (2007).
  • Tamdy A, El Louali F, Ounzar M et al. Multiple mycotic aneurysms reveal Staphylococcus lugdunensis endocarditis in a young patient. Heart Lung40(4), 352–357 (2011).
  • Spanu T, Rigante D, Tamburrini G et al. Ventriculitis due to Staphylococcus lugdunensis: two case reports. J. Med. Case Reports2, 267 (2008).
  • Elliott SP, Yogev R, Shulman ST. Staphylococcus lugdunensis: an emerging cause of ventriculoperitoneal shunt infections. Pediatr. Neurosurg.35(3), 128–130 (2001).
  • Sandoe JA, Longshaw CM. Ventriculoperitoneal shunt infection caused by Staphylococcus lugdunensis. Clin. Microbiol. Infect.7(7), 385–387 (2001).
  • Fleurette J, Bes M, Brun Y et al. Clinical isolates of Staphylococcus lugdunensis and S. schleiferi: bacteriological characteristics and susceptibility to antimicrobial agents. Res. Microbiol.140(2), 107–118 (1989).
  • Ludlam H, Phillips I. Staphylococcus lugdunensis peritonitis. Lancet2(8676), 1394 (1989).
  • Bannerman TL, Rhoden DL, Mcallister SK, Miller JM, Wilson LA. The source of coagulase-negative staphylococci in the Endophthalmitis Vitrectomy Study. A comparison of eyelid and intraocular isolates using pulsed-field gel electrophoresis. Arch. Ophthalmol.115(3), 357–361 (1997).
  • Chiquet C, Pechinot A, Creuzot-Garcher C et al. Acute postoperative endophthalmitis caused by Staphylococcus lugdunensis. J. Clin. Microbiol.45(6), 1673–1678 (2007).
  • Giese B, Glowinski F, Paprotka K et al. Expression of δ-toxin by Staphylococcus aureus mediates escape from phago-endosomes of human epithelial and endothelial cells in the presence of β-toxin. Cell Microbiol.13(2), 316–329 (2011).
  • Bera A, Biswas R, Herbert S, Gotz F. The presence of peptidoglycan O-acetyltransferase in various staphylococcal species correlates with lysozyme resistance and pathogenicity. Infect. Immun.74(8), 4598–4604 (2006).
  • Paulsson M, Petersson AC, Ljungh A. Serum and tissue protein binding and cell surface properties of Staphylococcus lugdunensis. J. Med. Microbiol.38(2), 96–102 (1993).
  • Zhang YQ, Ren SX, Li HL et al. Genome-based analysis of virulence genes in a non-biofilm-forming Staphylococcus epidermidis strain (ATCC 12228). Mol. Microbiol.49(6), 1577–1593 (2003).
  • Von Eiff C, Peters G, Heilmann C. Pathogenesis of infections due to coagulase-negative staphylococci. Lancet Infect. Dis.2(11), 677–685 (2002).
  • Stout RD, Ferguson KP, Li YN, Lambe DW Jr. Staphylococcal exopolysaccharides inhibit lymphocyte proliferative responses by activation of monocyte prostaglandin production. Infect. Immun.60(3), 922–927 (1992).
  • Grant CE, Sewell DL, Pfaller M, Bumgardner RV, Williams JA. Evaluation of two commercial systems for identification of coagulase-negative staphylococci to species level. Diagn. Microbiol. Infect. Dis18(1), 1–5 (1994).
  • Kloos WE, George CG. Identification of Staphylococcus species and subspecies with the MicroScan Pos ID and Rapid Pos ID panel systems. J. Clin. Microbiol.29(4), 738–744 (1991).
  • Mateo M, Maestre JR, Aguilar L et al. Genotypic versus phenotypic characterization, with respect to susceptibility and identification, of 17 clinical isolates of Staphylococcus lugdunensis. J. Antimicrob. Chemother.56(2), 287–291 (2005).
  • Carroll KC, Weinstein MP. Manual of Clinical Microbiology. ASM Press, Washington DC, USA (2007).
  • Leung MJ, Nuttall N, Pryce TM, Coombs GW, Pearman JW. Colony variation in Staphylococcus lugdunensis. J. Clin. Microbiol.36(10), 3096–3098 (1998).
  • Fadel HJ, Patel R, Vetter EA, Baddour LM. The clinical significance of a single positive blood culture for Staphylococcus lugdunensis. J. Clin. Microbiol.49(4), 1697–1699 (2011).
  • Pinsky BA, Samson D, Ghafghaichi L, Baron EJ, Banaei N. Comparison of real-time PCR and conventional biochemical methods for identification of Staphylococcus lugdunensis. J. Clin. Microbiol.47(11), 3472–3477 (2009).
  • Arciola CR, Campoccia D, An YH et al. Prevalence and antibiotic resistance of 15 minor staphylococcal species colonizing orthopedic implants. Int. J. Artif. Organs29(4), 395–401 (2006).
  • Vandenesch F, Etienne J, Reverdy ME, Eykyn SJ. Endocarditis due to Staphylococcus lugdunensis: report of 11 cases and review. Clin. Infect. Dis.17(5), 871–876 (1993).
  • Higaki S, Kitagawa T, Morohashi M, Yamagishi T. Distribution and antimicrobial susceptibility of coagulase-negative staphylococci from skin lesions. J. Int. Med. Res.27(4), 191–195 (1999).
  • Goldstein EJ, Citron DM, Merriam CV, Warren YA, Tyrrell KL, Fernandez HT. In vitro activity of ceftobiprole against aerobic and anaerobic strains isolated from diabetic foot infections. Antimicrob. Agents Chemother.50(11), 3959–3962 (2006).
  • Woods W, Ramotar K, Lem P, Toye B. Oxacillin susceptibility testing of coagulase-negative staphylococci using the disk diffusion method and the Vitek GPS-105 card( small star, filled). Diagn. Microbiol. Infect. Dis42(4), 291–294 (2002).
  • Van Der Mee-Marquet N, Achard A, Mereghetti L, Danton A, Minier M, Quentin R. Staphylococcus lugdunensis infections: high frequency of inguinal area carriage. J. Clin. Microbiol.41(4), 1404–1409 (2003).
  • Hellbacher C, Tornqvist E, Soderquist B. Staphylococcus lugdunensis: clinical spectrum, antibiotic susceptibility, and phenotypic and genotypic patterns of 39 isolates. Clin. Microbiol. Infect.12(1), 43–49 (2006).
  • Frank KL, Reichert EJ, Piper KE, Patel R. In vitro effects of antimicrobial agents on planktonic and biofilm forms of Staphylococcus lugdunensis clinical isolates. Antimicrob. Agents Chemother.51(3), 888–895 (2007).
  • Tee W. Staphylococcus lugdunensis carrying the mecA gene causes catheter-associated bloodstream infection in premature neonate. J. Clin. Microbiol.41(1), 519–520 (2003).
  • Becker K, Pagnier I, Schuhen B et al. Does nasal cocolonization by methicillin-resistant coagulase-negative staphylococci and methicillin-susceptible Staphylococcus aureus strains occur frequently enough to represent a risk of false-positive methicillin-resistant S. aureus determinations by molecular methods? J. Clin. Microbiol.44(1), 229–231 (2006).
  • Pereira EM, Schuenck RP, Nouer SA, Santos KR. Methicillin-resistant Staphylococcus lugdunensis carrying SCCmec type V misidentified as MRSA. Braz. J. Infect. Dis.15(3), 293–295 (2011).
  • Kawaguchi E, Minamide W, Mori H, Igimi H. [The taxonomic distribution, characteristic and susceptibility against antimicrobial agents of methicillin-resistant staphylococci isolated from blood]. Kansenshogaku Zasshi70(11), 1147–1153 (1996).
  • Wu AB, Wang MC, Tseng CC et al. Clinical and microbiological characteristics of community-acquired Staphylococcus lugdunensis infections in Southern Taiwan. J. Clin. Microbiol.49(8), 3015–3018 (2011).
  • Kotsakis SD, Tzouvelekis LS, Zerva L, Liakopoulos A, Petinaki E. Staphylococcus lugdunensis strain with a modified PBP1A/1B expressing resistance to β-lactams. Eur. J. Clin. Microbiol. Infect. Dis. DOI: 10.1007/s10096-011-1289-8 (2011) (Epub ahead of print).
  • Wilson W, Taubert KA, Gewitz M et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation116(15), 1736–1754 (2007).
  • Mendes RE, Sader HS, Jones RN. Activity of telavancin and comparator antimicrobial agents tested against Staphylococcus spp. isolated from hospitalised patients in Europe (2007–2008). Int. J. Antimicrob. Agents36(4), 374–379 (2010).
  • Merino P, Arribi A, Gestoso I, Picazo J, Gimeno L, Del Potro E. Linezolid treatment of a prosthetic joint infection with Staphylococcus lugdunensis in a patient with multiple myeloma. Int. J. Antimicrob. Agents35(2), 203–204 (2010).
  • Baddour LM, Wilson WR, Bayer AS et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation111(23), e394–e434 (2005).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.